Neurava
PrivateLast Round
Grant
Apr 23, 2026
Total Funding Raised
$6.96M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neurava is a medical technology company that develops wearable diagnostic devices to monitor and alert for seizures and cardiorespiratory dysfunctions in patients with epilepsy to mitigate the risk of SUDEP.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Health IoT, Sensors
Business Model
B2B2C
Customer Profile
Hardware + Subscription, Subscription SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurava Comparables
Compare Neurava with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| monikit | 85% | |
| Epilert | 81% | |
| Smart Monitor | 81% |
Neurava Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 23, 2026 | ||||
| Seed | Apr 3, 2024 | ||||
| Seed | Nov 1, 2021 | ||||
| Grant | Apr 9, 2021 | ||||
| Pre Seed | Dec 19, 2019 |
Key People
Founding team and executive leadership
Neurava Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Biomedical Imaging and Bioengineering | Grant |
| Purdue Research Foundation | Seed |
| Elevate Ventures | Seed, Pre Seed |
| iO Life Ventures | Seed |
| UCB Ventures | Seed |
| SWPDC | Grant |
| National Institute of Neurological Disorders and Stroke (NINDS) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors grew 76% MoM, reaching 2.7K.
- Apr 26, 2026
Grew 60% QoQ from 5 to 8 employees.
Neurava Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neurava's valuation, stock price, and market status.
Is Neurava a public or private company?
Neurava is a private company.
What is the current stock price of Neurava?
Neurava is a private company with no public stock price. No recent secondary market data is available.
How much is Neurava worth (valuation)?
Valuation information for Neurava is not publicly available.
Can I buy Neurava stock?
Neurava shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Neurava's last funding round?
Neurava's most recent funding round was Seed on April 3, 2024.
Who are the main investors in Neurava?
Key investors in Neurava include Elevate Ventures, Life Science Angels.
Will Neurava IPO soon?
No public IPO plans have been announced for Neurava.
How can I track Neurava secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neurava's secondary market activity and sign up for updates.